Explore more publications!
Health Update Bahamas
Submit Press Release

Health Update Bahamas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Update Bahamas.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on September 25, 2025

Newsmatics to Showcase the Evolution of Press Releases for Boosting AI Reach at MarCom Summit
September 25, 2025

Newsmatics to Showcase the Evolution of Press Releases for Boosting AI Reach at MarCom Summit

Indeterminate EIN Presswire
Lytus Technologies Holdings PTV. Ltd. Announces 1-for-2,500 Reverse Stock Split
September 25, 2025

Lytus Technologies Holdings PTV. Ltd. Announces 1-for-2,500 Reverse Stock Split

Indeterminate GlobeNewswire
Crinetics Announces FDA Approval of PALSONIFY™ (paltusotine) for the Treatment of Adults with Acromegaly
September 25, 2025

Crinetics Announces FDA Approval of PALSONIFY™ (paltusotine) for the Treatment of Adults with Acromegaly

Indeterminate GlobeNewswire
Medirom Decides to Double Installation of Authentication Device “Orb” to 200 Stores, in Collaboration with “World” Co-founded by Sam Altman and Alex Blania
September 25, 2025

Medirom Decides to Double Installation of Authentication Device “Orb” to 200 Stores, in Collaboration with “World” Co-founded by Sam Altman and Alex Blania

Indeterminate GlobeNewswire
Kura Oncology and Kyowa Kirin Announce Publication of Pivotal Ziftomenib Data in Relapsed/Refractory NPM1-Mutated AML in the Journal of Clinical Oncology
September 25, 2025

Kura Oncology and Kyowa Kirin Announce Publication of Pivotal Ziftomenib Data in Relapsed/Refractory NPM1-Mutated AML in the Journal of Clinical Oncology

Indeterminate GlobeNewswire
Medicenna Announces Results of Annual Meeting of Shareholders
September 25, 2025

Medicenna Announces Results of Annual Meeting of Shareholders

Indeterminate GlobeNewswire
Organogenesis Provides Update on Second Phase 3 ReNu® Study
September 25, 2025

Organogenesis Provides Update on Second Phase 3 ReNu® Study

Indeterminate GlobeNewswire
Teva Releases Q3 2025 Aide Memoire
September 25, 2025

Teva Releases Q3 2025 Aide Memoire

Indeterminate GlobeNewswire
Teva to Host Conference Call to Discuss Third Quarter 2025 Financial Results at 8 a.m. ET on November 5, 2025
September 25, 2025

Teva to Host Conference Call to Discuss Third Quarter 2025 Financial Results at 8 a.m. ET on November 5, 2025

Indeterminate GlobeNewswire
Buying Guide 2025- most effective female libido booster pills in 2025 By OhYes
September 25, 2025

Buying Guide 2025- most effective female libido booster pills in 2025 By OhYes

Indeterminate GlobeNewswire
Medtimo Files Patent Infringement Complaint Against Allurion Technologies
September 25, 2025

Medtimo Files Patent Infringement Complaint Against Allurion Technologies

Indeterminate GlobeNewswire
LifeMD to Participate in the ROTH 4th Annual Healthcare Opportunities Conference
September 25, 2025

LifeMD to Participate in the ROTH 4th Annual Healthcare Opportunities Conference

Indeterminate GlobeNewswire
Option Care Health to Announce Third Quarter 2025 Financial Results and Host Conference Call
September 25, 2025

Option Care Health to Announce Third Quarter 2025 Financial Results and Host Conference Call

Indeterminate GlobeNewswire
CapsoVision to Participate in the 4th Annual ROTH Healthcare Opportunities Conference
September 25, 2025

CapsoVision to Participate in the 4th Annual ROTH Healthcare Opportunities Conference

Indeterminate GlobeNewswire
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 25, 2025

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Harrow Launches Harrow Access for All (HAFA)
September 25, 2025

Harrow Launches Harrow Access for All (HAFA)

Indeterminate GlobeNewswire
Xenon Announces Upcoming Investor Webinar to Discuss Early-Stage Ion Channel Programs for the Potential Treatment of Pain
September 25, 2025

Xenon Announces Upcoming Investor Webinar to Discuss Early-Stage Ion Channel Programs for the Potential Treatment of Pain

Indeterminate GlobeNewswire
Cidara Therapeutics Announces First Participants Dosed in Phase 3 ANCHOR Trial Evaluating CD388 for the Prevention of Seasonal Influenza in High-Risk Populations
September 25, 2025

Cidara Therapeutics Announces First Participants Dosed in Phase 3 ANCHOR Trial Evaluating CD388 for the Prevention of Seasonal Influenza in High-Risk Populations

Indeterminate GlobeNewswire
Buying Guide 2025- Pills to Increase Sex Drive Female 2025 -Start Your Libido Life Today with Oh yes
September 25, 2025

Buying Guide 2025- Pills to Increase Sex Drive Female 2025 -Start Your Libido Life Today with Oh yes

Indeterminate GlobeNewswire
Scilex Holding Company Announces $150 Million Strategic Bitcoin Investment in Datavault AI
September 25, 2025

Scilex Holding Company Announces $150 Million Strategic Bitcoin Investment in Datavault AI

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions